WINDLAS BIOTECH
Back to Income Statement
|
WINDLAS BIOTECH Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹760 Cr | ₹631 Cr | ₹513 Cr | ₹466 Cr | ₹428 Cr |
What is the latest Revenue of WINDLAS BIOTECH ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹760 Cr |
| Mar2024 | ₹631 Cr |
| Mar2023 | ₹513 Cr |
| Mar2022 | ₹466 Cr |
| Mar2021 | ₹428 Cr |
How is Revenue of WINDLAS BIOTECH Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹760 Cr | 20.43 | |
| Mar2024 | ₹631 Cr | 22.97 | |
| Mar2023 | ₹513 Cr | 10.12 | |
| Mar2022 | ₹466 Cr | 8.96 | |
| Mar2021 | ₹428 Cr | - | |
Compare Revenue of peers of WINDLAS BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WINDLAS BIOTECH | ₹1,669.6 Cr | -1.4% | -6.2% | -13.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,926.0 Cr | -3% | -1.9% | 7.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,062.0 Cr | -3.3% | -0.7% | -1.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,806.0 Cr | -3.8% | 2.8% | 36.4% | Stock Analytics | |
| CIPLA | ₹112,910.0 Cr | -3% | 3% | -6.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,755.0 Cr | -4.3% | -2% | 2.5% | Stock Analytics | |
WINDLAS BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WINDLAS BIOTECH | -1.4% |
-6.2% |
-13.4% |
| SENSEX | -2% |
-3.8% |
-8.6% |
You may also like the below Video Courses